GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spago Nanomedical AB (XSAT:SPAG BTA) » Definitions » Other Long-Term Liabilities

Spago Nanomedical AB (XSAT:SPAG BTA) Other Long-Term Liabilities : kr0.12 Mil (As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Spago Nanomedical AB Other Long-Term Liabilities?

Spago Nanomedical AB's other long-term liabilities for the quarter that ended in Mar. 2025 was kr0.12 Mil.

Spago Nanomedical AB's quarterly other long-term liabilities increased from Sep. 2024 (kr0.08 Mil) to Dec. 2024 (kr0.10 Mil) and increased from Dec. 2024 (kr0.10 Mil) to Mar. 2025 (kr0.12 Mil).

Spago Nanomedical AB's annual other long-term liabilities increased from Dec. 2022 (kr0.00 Mil) to Dec. 2023 (kr0.04 Mil) and increased from Dec. 2023 (kr0.04 Mil) to Dec. 2024 (kr0.10 Mil).

Spago Nanomedical AB Other Long-Term Liabilities Historical Data

The historical data trend for Spago Nanomedical AB's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spago Nanomedical AB Other Long-Term Liabilities Chart

Spago Nanomedical AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.04 0.10

Spago Nanomedical AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.07 0.08 0.10 0.12

Spago Nanomedical AB Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Spago Nanomedical AB Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Spago Nanomedical AB's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Spago Nanomedical AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spago Nanomedical AB (XSAT:SPAG BTA) » Definitions » Other Long-Term Liabilities
Comparable Companies
OSTO:BIOSGN OSTO:SIMRIS B OSTO:NXTCL XSAT:DEX XSAT:BIOWKS XSAT:ABERA OSTO:NICA OSTO:PILA OSTO:ISOFOL OSTO:BIOVIC B VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX ONC XKRX:068270 BNTX
Traded in Other Exchanges
SPAGO:Sweden
Address
Scheelevagen 22, Lund, SWE, SE-223 63
Website
https://www.spagonanomedical.se
Spago Nanomedical AB is a nanomedicine company in the field of cancer diagnosis and treatment. The company's product includes SpagoPix and Tumorad. The SpagoPix product aims to improve cancer diagnosis with magnetic resonance imaging through the previous detection of tumors and metastases. The Tumorad products focus on the development of a completely new form of radionuclide therapy for tumor-selective radiation therapy of cancer. The company's development projects are based on a platform of polymeric materials with various properties for the precise diagnosis and treatment of life-threatening and debilitating diseases.

Spago Nanomedical AB Headlines

No Headlines